Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005430
Filing Date
2014-11-10
Accepted
2014-11-10 17:05:12
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20140930.htm 10-Q 1214930
2 EX-31.1 snss-ex311_201409308.htm EX-31.1 15537
3 EX-31.2 snss-ex312_201409307.htm EX-31.2 15800
4 EX-32.1 snss-ex321_201409306.htm EX-32.1 9727
5 GRAPHIC g201411080006489671395.jpg GRAPHIC 2799
  Complete submission text file 0001564590-14-005430.txt   5850818

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20140930.xml EX-101.INS 942902
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20140930.xsd EX-101.SCH 37658
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20140930_cal.xml EX-101.CAL 37185
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20140930_def.xml EX-101.DEF 89394
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20140930_lab.xml EX-101.LAB 262592
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20140930_pre.xml EX-101.PRE 187359
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 141209598
SIC: 2834 Pharmaceutical Preparations